Yoshinori Takahashi

USPTO Granted Patents = 30 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 10

Forward Citations = 331(Granted Patents)

Location History:

Utsunomiya, JP (1988 - 1992)
Hachioji, JP (2008 - 2010)
Tsukuba, JP (2006 - 2020)
Ibaraki, JP (2004 - 2021)

Company Filing History:

11 out of 530

Eisai R&d Management Co., Ltd.

patents

7 out of 677

Eisai Company, Limited

Maruha Nichiro Corporation

patents

6. 2 out of 5

Maruha Nichiro Foods, Inc.

patents

7. 1 out of 1,164

Olympus Medical Systems Corporation

patents

where one patent can have more than one assignee

Years Active: 1988-2021

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11208429 - Modified nucleic acid monomer compound and oligonucleic acid analog (2021-12-28),

2. 10947193 - Cationic lipid (2021-03-16),

3. 10526603 - Double-stranded ribonucleic acid capable of suppressing expression of complement C5 (2020-01-07),

4. 10513538 - Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same (2019-12-24),

5. 10501416 - Cationic lipid (2019-12-10),

6. 9868764 - Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same (2018-01-16),

7. 9458176 - Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative (2016-10-04),

8. 8530504 - Pyrazolothiazole compound (2013-09-10),

9. 8431603 - [object Object] (2013-04-30),

10. 8399014 - Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof (2013-03-19),

11. 8305427 - Image processor and endoscope apparatus (2012-11-06),

12. 8283311 - Peptide-containing food intake regulator (2012-10-09),

13. 7772249 - Imidazo[1,2-b]pyridazine compound (2010-08-10),

14. 7670286 - Electronic endoscopic device having a color balance adjustment system (2010-03-02),

15. 7625925 - Pyrazolo[1,5-a]pyridines and medicines containing the same (2009-12-01),

Title: **Yoshinori Takahashi: A Pioneer in Modified Nucleic Acids and Cationic Lipids**

Introduction

Yoshinori Takahashi, based in Ibaraki, Japan, has made significant contributions to the field of biochemistry and molecular biology. With a remarkable portfolio of 28 patents, he is recognized for his innovative research in modified nucleic acid compounds and lipid molecules designed for effective nucleic acid delivery.

Latest Patents

Among Yoshinori's latest inventions are a modified nucleic acid monomer compound and a cationic lipid. The modified nucleic acid monomer compound features a unique backbone, including options like 2-ethylglycerol or methoxymethyl-1,3-propanediol, as alternatives to the typical ribose or deoxyribose backbones. This innovation results in an oligonucleic acid analogue that exhibits exceptional biological stability and target gene silencing activity. Furthermore, his cationic lipid invention offers a reliable vehicle for nucleic acid delivery to the cytoplasm, utilizing specific structures defined in his formula, which includes alkylene and alkyl groups ranging from 3 to 24 carbon atoms.

Career Highlights

Yoshinori Takahashi has accumulated his expertise through his roles in reputable organizations, notably at Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His work at these institutions has been pivotal in pushing the boundaries of research and applications in pharmaceutical sciences and biotechnology.

Collaborations

Throughout his career, Yoshinori has collaborated with noteworthy colleagues such as Kogyoku Shin and Hisashi Shibata. These partnerships have fostered an environment of innovation and have contributed to the success of his numerous patents and research endeavors.

Conclusion

Yoshinori Takahashi stands out as a significant inventor in the realm of biochemistry, with his advanced patents that pave the way for new therapeutic strategies and technologies. His ongoing work continues to inspire advancements in the field of nucleic acids and their applications in medicine and biotechnology.

This text is generated by artificial intelligence and may not be accurate.